Product Description: Bemiltenase alfa is a hemostatic agent targeting coagulation factor X (FX). Bemiltenase alfa activates FX and promotes the conversion of prothrombin to thrombin, and thrombin can further transform fibrinogen into fibrin, forming a stable blood clot, thus exerting hemostatic activity. Bemiltenase alfa is promising for research of bleeding symptoms with hemophilia[1].
Formula: N/A
References: [1]Liu W, et al. A Specific Coagulation Factor X Activator for on-Demand Treatment in Hemophilia with Inhibitors[J]. Blood, 2024, 144: 1213.
CAS Number: 2766038-73-5
Molecular Weight: N/A
Research Area: Cardiovascular Disease
Target: Factor XI